BOLD 8-K 2026-06-23

Boundless Bio, Inc. (BOLD) 8-K dated 2026-06-23 — accession 0001193125-26-278570.

Boundless Bio, Inc. (BOLD) is a biotechnology company listed on US.

Boundless Bio, Inc. filed a 8-K on 2026-06-23. Accession 0001193125-26-278570.

This 8-K covers: Material agreement (Item 1.01), Exit or restructuring costs (Item 2.05), Unregistered share sale (Item 3.02), Change in control (Item 5.01), Director/officer change (Item 5.02), Reg FD disclosure (Item 7.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for BOLD is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The BOLD SEC hub lists recent forms. The stock page is the research view.